Skip to main content
SpringerLink
Log in
Book cover

Clinical Nephrotoxins pp 339–351Cite as

Diuretics

  • Chapter

  • 263 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Puschett JB, Winaver J. Effects of diuretics on renal function. In: Handbook of physiology. Section 8 renal physiology. Windhager EE (editor). Oxford Press, New York 1992; p. 2335–406.

    Google Scholar 

  2. Schnermann J, Wright FS, Davis JM, Stackerberg WV, Grill G. Regulation of superficial nephron filtration rate by tubuloglomerular feedback. Pflugers Arch 1970; 318: 147–75.

    Article  CAS  PubMed  Google Scholar 

  3. Thurau K, Schnermann J, Nagel W, Horster M, Wahl M. Composition of tubular fluid in the macula densa segment as a factor regulating the function of the juxtaglomerular apparatus. Circ Res 1967; 20–21 (Suppl 2): 79–90.

    Google Scholar 

  4. Tucker BJ, Steiner RW, Gushwa LC, Blantz RC. Studies on the tubulo-glomerular feedback system in the rat. The mechanism of reduction in filtration rate with benzolamide. J Clin Invest 1978; 62: 993–1004.

    CAS  PubMed  Google Scholar 

  5. Puschett JB, Goldberg M. The acute effects of furosemide on acid and electrolyte excretion in man. J Lab Clin Med 1968; 71: 666–677.

    CAS  PubMed  Google Scholar 

  6. Burke TJ, Duchin KL. Glomerular filtration during furosemide diuresis in the dog. Kidney Int 1979; 16: 672–680.

    CAS  PubMed  Google Scholar 

  7. Hook JB, Blatt AH, Brody MJ, Williamson HE. Effects of several saluretic-diuretic agents on renal hemodynamics. J Pharmacol Exp Ther 1966; 154: 667–673.

    CAS  PubMed  Google Scholar 

  8. Vander AJ, Carlson J. Mechanism of the effects of furosemide on renin secretion in anesthetized dogs. Circ Res 1969; 25: 145–152.

    CAS  PubMed  Google Scholar 

  9. Tucker BJ, Blantz RC. Effect of furosemide administration on glomerular and tubular dynamics in the rat. Kidney Int 1984; 26: 112–121.

    CAS  PubMed  Google Scholar 

  10. Meyer P, Menard J, Papanicolaou N, Alexandre JM, Devaux C, Milliez P. Mechanism of renin release following furosemide diuresis in the rabbit. Am J Physiol 1968; 215: 908–915.

    CAS  PubMed  Google Scholar 

  11. Brenner BM, Keimowitz RI, Wright FS, Berliner RW. An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest 1969; 48: 290–300.

    CAS  PubMed  Google Scholar 

  12. Burke TJ, Robinson RR, Clapp JR. Determinants of the effect of furosemide on the proximal tubule. Kidney Int 1972; 1:12–18.

    CAS  PubMed  Google Scholar 

  13. Birtch AG, Zakheim RM, Jones LG, Barger AC. Redistribution of renal blood flow produced by furosemide and ethacrynic acid. Cir Res 1967; 21: 869–878.

    CAS  Google Scholar 

  14. Dluhy AG, Wolf GL, Lauler DP. Vasodilator properties of ethacrynic acid in the perfused dog kidney. Clin Sci 1970; 38: 347–357.

    CAS  PubMed  Google Scholar 

  15. McNay JL, Kishimoto T. Selective renal vascular effects of ethacrynic acid. J Pharmacol Exp Ther 1970; 174: 159–168.

    CAS  PubMed  Google Scholar 

  16. Early LE, Friedler RM. Tubular effects of ethacrynic acid. J Clin Invest 1964; 43: 1495–1506.

    Google Scholar 

  17. Olsen UB. Indomethacin inhibition of bumetanide diuresis in dogs. Acta Pharmacol Toxicol 1975; 37: 65–78.

    CAS  Google Scholar 

  18. Puschett JB, Sylk D, Teredesai PR. Uncoupling of proximal sodium bicarbonate from sodium phosphate transport by bumetanide. Am J Physiol 1978; 235 (Renal Fluid Electrolyte Physiol 4): F403–F408.

    CAS  PubMed  Google Scholar 

  19. Olsen UB. Prostaglandin/kinin activity related to changed renal compliance after bumetanide in dogs. Acta Pharmacol Toxicol 1977; 40: 430–438.

    CAS  Google Scholar 

  20. Olsen UB, Ahnfelt-Ronne I. Bumetanide induced increase of renal blood flow in conscious dogs and its relation to local renal hormones (PGE, kallikrein and renin). Acta Pharmacol Toxicol 1976; 38: 219–228.

    CAS  Google Scholar 

  21. Olsen UB, Ahnfelt-Ronne I. Renal cortical blood redistribution after bumetanide related to heterogenicity of cortical prostaglandin metabolism in dogs. Acta Physiol Scand 1976; 97: 251–257.

    CAS  PubMed  Google Scholar 

  22. Bourke E, Asbury MJA, O’Sullivan S. Gatenby PBB. The sites of action of bumetanide in man. Eur J Pharmacol 1973; 23: 283–289.

    Article  CAS  PubMed  Google Scholar 

  23. Karlander S-G, Henning R, Lundvall O. Renal effects of bumetanide, a new saluretic agent. Eur J Clin Pharmacol 1973; 6: 220–233.

    Article  CAS  PubMed  Google Scholar 

  24. Jayakumar S, Puschett JB. Study of the sites and mechanism of action of bumetanide in man. J Pharmacol Exp Ther 1977; 201: 251–258.

    CAS  PubMed  Google Scholar 

  25. Walter SJ, Laycock JF, Shirley DG. A micropuncture study of proximal tubular function after acute hydrochlorothiazide administration to Brattleboro rats with diabetes insipidus. Clin Sci 1979; 57: 427–434.

    CAS  PubMed  Google Scholar 

  26. Krause HH, Dume T, Koch KM, Ochwadt B. Intratubularer druck, glomerularer capillardruck und glomerulumfiltrat nach furosemid und hydrochlorothiazid. Pflugers Arch 1967; 295: 80–89.

    Article  CAS  Google Scholar 

  27. Cassin S, Vogh B. Effect of hydrochlorothiazide on renal blood flow and clearance of para-aminohippurate and creatinine. Proc Soc Exp Biol Med 1966; 122: 970–973.

    CAS  PubMed  Google Scholar 

  28. Gadllah MF, Lynn M, Work J. Case Report: Mannitol nephrotoxicity syndrome: role of hemodialysis and postulate of mechanisms. Am J Med Sci 1995; 309(4): 219–222.

    Google Scholar 

  29. Better OS, Rubinstein I, Winaver JM, Knochel JP. Mannitol therapy revisited (1940–1997). Kidney Int 1997; 51: 886–894.

    Google Scholar 

  30. Goldwasser P, Fotino S. Acute renal failure following massive mannitol infusion: Appropriate response of tubuloglomerular feedback? Arch Intern Med 1984; 144:2214–2216.

    Article  CAS  PubMed  Google Scholar 

  31. Whelan TV, Bacon ME, Madden M, Patel TG, Handy R. Acute renal failure associated with mannitiol intoxication. Arch Intern Med 1984; 144: 2053–2055.

    Article  CAS  PubMed  Google Scholar 

  32. Horgan KJ, Ottaviano YL, Watson AJ. Acute renal failure due to mannitol intoxication. Am J Nephrol 1989; 9:106–109.

    CAS  PubMed  Google Scholar 

  33. Rello J, Trigner C, Sanchez JM, Net A. Acute renal failure following massive mannitol infusion. Nephron 1989; 53: 377–378.

    CAS  PubMed  Google Scholar 

  34. Weaver A, Sica DA. Mannitol-induced acute renal failure. Nephron. 1987; 45: 233–235.

    CAS  PubMed  Google Scholar 

  35. Rabetoy GM, Fredericks MR, Hostetteler CF. Where the kidney is concerned, how much mannitol is too much? Ann Pharmacother 1993; 27: 25–28.

    CAS  PubMed  Google Scholar 

  36. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine 1990; 69(3): 153–159.

    CAS  PubMed  Google Scholar 

  37. Mansbach AB, Madden SC, Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran. Lab Invest 1962; 11: 421–432.

    Google Scholar 

  38. Dalgaard OZ, Pederson KJ. Some observations of the fine structure of human kidneys in acute anuria and osimotic diuresis. In: Renal Biopsy. Wolstenholme GEW, Cameron MP (editors). Little Brown, New York, 1962; p...

    Google Scholar 

  39. Read RC, Johnson JA, Vick JA, Meyre MW. Vascular effects of hypertonic solutions. Circ Research 1960; 8: 538–548.

    CAS  Google Scholar 

  40. Krishnamurty VSR, Adams HR, Smitherman TC, Templeton GH, Willerson JT. Influence of mannitol on contractile responses of isolated perfused arteries. Am J Physiol 1977; 232(1): H59–66.

    CAS  PubMed  Google Scholar 

  41. Temes SP, Lilien OM, Chamberlain W. A direct vasoconstricter effect of mannitol on the renal artery. Surg Gynecol Obstet 1975; 141: 223–226.

    CAS  PubMed  Google Scholar 

  42. Councilman WT. Acute interstitial nephritis. J Exp Med 1898; 3: 393–420.

    Article  Google Scholar 

  43. Bakken K. The allergic reaction of the Kidney to sulphonamide medication. J Pathol Bacteriol 1947; 59: 501–504.

    Article  Google Scholar 

  44. Baldwin DS, Levine BB, McCluskey RT, Gallo GR. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med 1968; 279: 1245–1252.

    CAS  PubMed  Google Scholar 

  45. Simenhoff ML, Guild WR, Dammin GJ. Acute diffuse interstitial nephritis: review of the literature and case report. Am J Med 1968, 44: 618–625.

    Article  CAS  PubMed  Google Scholar 

  46. Schwarz A, Krause PH, Kunzendorf U, Keller F, Distier A. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 2000; 54(3): 179–190.

    CAS  PubMed  Google Scholar 

  47. Lyons H, Pinn VW, Cortell S, Cohen JJ, Harrington JT. Allergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome. N Engl J Med 1973; 288: 124–128.

    CAS  PubMed  Google Scholar 

  48. Fialk MA, Romankiewicz J, Perrone F, Sherman RL. Allergic interstitial nephritis with diuretics. Ann Intern Med 1974; 81: 403–404.

    CAS  PubMed  Google Scholar 

  49. Fuller TJ, Barcenas CG, White MG. Diuretic-induced interstitial nephritis. JAMA 1976; 235: 1998–1999.

    Article  CAS  PubMed  Google Scholar 

  50. Magil AB, Ballon HS, Cameron EG, Rae A. Acute interstitial nephritis associated with thiazide diuretics. Am J Med 1980; 69: 939–943.

    CAS  PubMed  Google Scholar 

  51. Bailey RR, Lynn KL, Drennan CJ, Turner GAL. Triamterene-induced acute interstitial nephritis. Lancet 1982; 1: 226.

    CAS  PubMed  Google Scholar 

  52. Roy LF, Villeneuve J-P, Dumont A, Dufresne LR, Duran MA, Morin C, Jobin J. Irreversible renal failure associated with triamterene. Am J Nephrol 1991; 11(6): 486–488.

    CAS  PubMed  Google Scholar 

  53. Peskoe ST, McMillan JH, Lorch A, Sussman H, Ozawa T. Reversible acute renal failure associated with chlorthalidone therapy: possible drug-induced interstitial nephritis. J Med Assoc Ga 1978; 67: 17–18.

    CAS  PubMed  Google Scholar 

  54. Ooi BS, Jao W, First MR, Mancilla R, Pollak VE. Acute interstitial nephritis. A clinical and pathologic study based on renal biopsies. Am J Med 1975; 59: 614–28.

    Article  CAS  PubMed  Google Scholar 

  55. Walker RG, Whitworth JA, Kincaid-Smith PS. Acute interstitial nephritis in a patient taking tienilic acid. Brit Med J 1980; 280: 1212.

    CAS  PubMed  Google Scholar 

  56. Newstead CG, Moore RH, Barnes AJ. Interstitial nephritis associated with indapamide. Brit Med J 1990; 300: 1344.

    CAS  PubMed  Google Scholar 

  57. Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q J Med 1983; 52: 194–211.

    CAS  PubMed  Google Scholar 

  58. Ten RM, Torres VE, Milliner DW, Schwab TR, Holley KE, Gleich GJ. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc 1988; 63: 921–930.

    CAS  PubMed  Google Scholar 

  59. Kleinknecht D, Vanhille Ph, Morel-Maroger L, Kanfer A, Lemaitre V, Mery JP, Laederich J, Callard P. Acute interstitial nephritis due to drug hypersensitivity. An up-to-date review with a report of 19 cases. Adv Nephrol 1983; 12: 277–308.

    CAS  Google Scholar 

  60. Bennett WM. Diuretic toxicity and drug interactions. In: Diuretics: physiology, pharmacology and clinical use. Dirks JH, Sutton RAL (editors). WB Saunders, Philadelphia 1986; p. 362–373.

    Google Scholar 

  61. Grünfeld J-P, Kleinknecht D, Droz D. Acute interstitial nephritis. In: Diseases of the kidney, 4th edition. Schrier RW, Gottschalk CW (editors). Little Brown, Boston 1988; p. 1461–1487.

    Google Scholar 

  62. Magil AB. Drug-induced acute interstitial nephritis with granulomas. Hum Pathol 1983; 13: 36–41.

    Google Scholar 

  63. Larsson GB, Langer L, Nässberger L. Thiazide-induced kidney damage with circulating antibodies against myeloperoxidase and cardiolipin. J Intern Med 1993; 233: 493–494.

    CAS  PubMed  Google Scholar 

  64. Bjornberg A, Gesslen H. Thiazides: a cause of necrotizing vasculitis. Lancet 1965; 2: 982.

    CAS  PubMed  Google Scholar 

  65. Grunwald MH, Halevy S, Livni E. Allergic vasculitis induced by hydrochlorothiazide: confirmation by mast cell degranulation test. Isr J Med Sci 1989; 25: 572–574.

    CAS  PubMed  Google Scholar 

  66. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris PA. Subacute cutaneous lupus erythematosis associated with hydrochlorothiazide treatment. Ann Intern Med 1985; 103: 49–51.

    CAS  PubMed  Google Scholar 

  67. Fitzgerald EW. Fatal glomerulonephritis complicating allergic purpura due to chlorothiazide. Arch Intern Med 1960; 105: 305–310.

    PubMed  Google Scholar 

  68. Kjellbo H, Stakeberg H, Mellgren J. Possibly thiazide-induced renal necrotizing vasculitis. Lancet 1965; 2: 1035–1035.

    Google Scholar 

  69. Cox NH, Hodkin P. Vasculitis due to metolazone. Postgrad Med J 1991; 67: 860.

    CAS  PubMed  Google Scholar 

  70. Howlet SA. Renal failure associated with acetazolamide therapy for glaucoma. South Med J 1975; 68: 504–506.

    Google Scholar 

  71. West AE. Hematuria in acetazolamide (Diamox) therapy. Crit Care Med 1982; 10: 197.

    CAS  PubMed  Google Scholar 

  72. Higenbottam T, Ogg CS, Saxton HM. Acute renal failure from the use of acetazolamide (Diamox). Postgrad Med J 1978; 54: 127–128.

    CAS  PubMed  Google Scholar 

  73. Glustien AS, Fisher ER. Renal lesions of sulfonamide type after treatment with acetazolamide (Diamox). JAMA 1956; 106: 204–206.

    Google Scholar 

  74. Bertino JR, Rodman T, Myerson RM. Thrombocytopenia and renal lesions associated with acetazolamide (Diamox) therapy. Arch Intern Med 1957; 99: 1006–1008.

    CAS  Google Scholar 

  75. Orchard RT, Taylor DJE, Parkins RA. Sulphonamide crystalluria with acetazolamide. Brit Med J 1972; 3: 646.

    CAS  PubMed  Google Scholar 

  76. Yates-Bell JG. Renal colic and anuria from acetazolamide. Brit Med J 1958; 2: 1392.

    Google Scholar 

  77. Persky L, Chambers D, Potts A. Calculus formation and ureteral colic following acetazolamide (Diamox) therapy. JAMA 1956; 161: 1625–1626.

    CAS  Google Scholar 

  78. Parfitt AM. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis. Arch intern Med 1969; 124: 736–740.

    CAS  PubMed  Google Scholar 

  79. Davis DW. Acetazolamide therapy with renal complications. Brit Med J 1959; 1: 214–215.

    Google Scholar 

  80. Gordon EE, Sheps SG. Effect of acetazolamide on citrate excretion and formation of renal calculi. N Engl J Med 1957; 256: 1215–1219.

    CAS  PubMed  Google Scholar 

  81. Mackenzie AR. Acetazolamide-induced renal stone. J Urol 1960; 84: 453–455.

    CAS  PubMed  Google Scholar 

  82. Leopold IH. Ureteric calculi due to long-term use of carbonic anhydrase inhibitors. JAMA 1968; 208: 538.

    Google Scholar 

  83. Kass MA, Kolker AE, Gordon M, Goldberg I, Gieser DK, Krupin T, Becker B. Acetazolamide and Urolithiasis. Opthalmology 1981; 88: 261–265.

    CAS  Google Scholar 

  84. Resor SR, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile epilepsy. Neurology 1990; 40: 1677–1681.

    PubMed  Google Scholar 

  85. Tawil R, Moxley RT, Griggs RC. Acetazolamide-induced nephroliathsis: Implications for the treatment of neuromuscular disorders. Neurology 1993; 43: 1105–1106.

    CAS  PubMed  Google Scholar 

  86. Hagashihara E, Nutahara K, Takeuchi T, Nobyukis S, Araie M, Aso Y. Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors responses to citrate. J Urol 1991; 145: 942–948.

    Google Scholar 

  87. Ettinger B, Weil E, Mandel NS, Darling S. Triamterene-induced nephrolithiasis. Ann Intern Med 1979; 91: 745–746.

    CAS  PubMed  Google Scholar 

  88. Ettinger B, Oldroyd NO, Sorgel F. Triamterene nephrolithiasis. JAMA 1980; 244: 2443–2445.

    Article  CAS  PubMed  Google Scholar 

  89. Fairley KF, Woo KT, Birch DF, Leaker BR, Ratnaike S. Triamterene induced crystalluria and cylinduria: clinical and experimental studies. Clin Nephrol 1986; 26(4): 169–173.

    CAS  PubMed  Google Scholar 

  90. Sica DA, Gehr TWB. Triamterene and the kidney. Nephron 1989; 51: 454–461.

    CAS  PubMed  Google Scholar 

  91. Greenburg A. Diuretic complications. Am J Med Sci 2000; 319(1): 10–24.

    Google Scholar 

  92. Carr MC, Prien EL, Babayan RK. Triamterene nephrolithiasis: renewed attention is warranted. J Urol 1990; 144: 1339–1340.

    CAS  PubMed  Google Scholar 

  93. White DJ, Nancollas GH. Triamterene renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization. Calcif. Tissue Int 1987; 40: 79.

    CAS  PubMed  Google Scholar 

  94. DeMartini FE, Wheaton EA, Healey LA, Larugh JH. Effect of chlorothiazide on renal excretion of uric acid. Am J Med 1962; 32: 572–577.

    Article  Google Scholar 

  95. Puschett JB. Clinical uses of diuretics. In: Handbook of experimental pharmacology. Diuretics. Greger R, Knauf H, Mutschler E (editors). Springer-Verlag, Berlin (in press).

    Google Scholar 

  96. Steele TH. Importance and pathogenesis of diuretic-induced hyperurcemia. In: Diuretics IV. Chemistry, pharmacology and clinical applications. Puschett JB, Greenberg A, (editors). Elsevier, Amsterdam 1993; p. 231–238.

    Google Scholar 

  97. Carlsen JE, Kober L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, anti-hypertensive effect, and adverse biochemical effects. Br Med J 1990; 300: 975–978.

    CAS  Google Scholar 

  98. Berglund G, Andersson O. Low doses of hydrochlorothiazide in hypertension. Antihypertensive and metabolic effects. Eur J Pharmacol 1976; 10: 177–182.

    Google Scholar 

  99. Liang MH, Fries JF. Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med 1978; 88: 666–670.

    CAS  PubMed  Google Scholar 

  100. Hall AP, Barney PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 1967; 42: 27–37.

    Article  CAS  PubMed  Google Scholar 

  101. Gutman AB, Yü TF. Renal function and gout with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med 1957; 23: 600–622.

    CAS  PubMed  Google Scholar 

  102. Fessel WJ, Siegelaub AB, Johnson ES. Correlation and consequences of asymptomatic hyperuricemia. Arch Intern Med 1973; 132: 44–54.

    Article  CAS  PubMed  Google Scholar 

  103. Fessel WJ. Renal outcomes of gout and hyperuricemia. Am J Med 1979; 67: 74–82.

    Article  CAS  PubMed  Google Scholar 

  104. Klinenberg JR, Gonick HC, Dornfeld L. Renal function abnormalities in patients with asymptomatic hyperuricemia. Arthritis Rheum 1975; 18 (suppl): 725–730.

    CAS  PubMed  Google Scholar 

  105. Briney WG, Ogden D, Bartholomew B, Smythe CJ. The influence of allopurinol on renal function in gout. Arthritis Rheum 1975; 18 (suppl): 877–81.

    CAS  PubMed  Google Scholar 

  106. Berger L, Yü TF. Renal function in gout IV. Analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 1975; 59: 605–613.

    Article  CAS  PubMed  Google Scholar 

  107. Rosenfeld JB. Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects. Adv Exp Med Biol 1974; 41: 581–596.

    CAS  PubMed  Google Scholar 

  108. Steele TH, Manuel MA, Boner G. Diuretics, urate excretion and sodium reabsorption: effect of acetazolamide and urinary alkalinization. Nephron 1975; 14: 48–61.

    Google Scholar 

  109. Alon US, Scagliotti D, Garola RE. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr 1994; 125: 149–151.

    CAS  PubMed  Google Scholar 

  110. Downing GJ, Egelhoff JC, Daily DK, Thomas MK, Alon U. Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years. J Pediatr 1992; 120: 599–604.

    CAS  PubMed  Google Scholar 

  111. Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 1982; 70: 360–363.

    CAS  PubMed  Google Scholar 

  112. Jacinto JS, Modanlou HD, Crade M, Strauss AA, Bosu SK. Renal calcification incidence in very low birth weight infants. Pediatrics 1988; 81: 31–35.

    CAS  PubMed  Google Scholar 

  113. Saarela T, Lanning P, Koivisto M, Paavilainen T. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr 1999; 158: 668–672.

    Article  CAS  PubMed  Google Scholar 

  114. Saarela T, Lanning P, Koivisto M. Prematurity-associated nephrocalcinosis and kidney function in early childhood. Pediatr Nephrol 1999; 13: 886–890.

    Article  CAS  PubMed  Google Scholar 

  115. Pope, IV JC, Trusler LA, Klein AM, Walsh WF, Yared A, Brock, III JW. The natural history of nephrocalcinosis in premature infants treated with loop diuretics. J Urol 1996; 156: 709–712.

    PubMed  Google Scholar 

  116. Atkinson SA, Shah JK, McGee C, Steele BT. Mineral excretion in premature infants receiving various diuretic therapies. J Pediatr 1988; 113: 540–545.

    CAS  PubMed  Google Scholar 

  117. Cohanim M, Yendt ER. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis. Invest Urol 1980; 18: 170–173.

    CAS  PubMed  Google Scholar 

  118. Constanzo LS, Weiner IM. On the hypercalciuric action of chlorothiazide. J Clin Invest 1984; 54: 628.

    Google Scholar 

  119. Campfield T, Braden G, Flynn-Valone P, Powell S. Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants. Pediatrics 1997; 99: 814–818.

    Article  CAS  PubMed  Google Scholar 

  120. Puschett JB, O’Donovan R. Renal actions and uses of diuretics. In: Textbook of nephrology. Massry SG, Glassock RJ (editors). Williams & Wilkins, Baltimore (in press).

    Google Scholar 

  121. Puschett JB, Rastegar A. Comparative study of the effects of metolazone and other diuretics on potassium excretion. Clin Pharmacol Ther 1973; 15: 397–405.

    Google Scholar 

  122. Giebisch G. Effect of diuretics on renal transport of potassium. Methods Pharmacol 1976; 4A: 121–164.

    CAS  Google Scholar 

  123. Wright FS, Giebisch G. Regulation of potassium excretion. In: The kidney: physiology and pathophysiology. Seldin DW, Giebisch G (editors). Raven Press, New York; 1992: p. 2206–2247.

    Google Scholar 

  124. Lawson DH. Allergic reaction to potassium chloride. Q J Med 1974; 43: 443–450.

    Google Scholar 

  125. Kassirer JP, Harrington JT. Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy. Kidney Int 1977; 11: 505–515.

    CAS  PubMed  Google Scholar 

  126. Cremer W, Bock KD. Symptoms and course of chronic hypokalemic nephropathy in man. Clin Nephrol 1977; 7: 112–119.

    CAS  PubMed  Google Scholar 

  127. O’Donovan RA, Muhammedi M, Puschett JB. Diuretics in the therapy of hypertension: current status. Am J Med Sci 1992; 304: 312–318.

    CAS  PubMed  Google Scholar 

  128. Conn JW, Johnson RD. Kaliopenic nephropathy. Am J Clin Nutr 1956; 4: 523–528.

    CAS  PubMed  Google Scholar 

  129. Relman AS, Schwartz WB. The kidney in potassium depletion. Am J Med 1958; 24: 764–773.

    Article  CAS  PubMed  Google Scholar 

  130. Cremer W, Blümcke S, Bock KD. Morphologie der kaliopenischen nephropathie beim menschen. Zentrabl Allg Path 1974; 118: 481–482.

    Google Scholar 

  131. Healy JJ, McKenna TJ, Canning B St J, Brien TG, Duffy GJ, Muldowney FP. Body composition changes in hypertensive subjects on long-term oral diuretic therapy. Brit Med J 1970; 1: 716–719.

    CAS  PubMed  Google Scholar 

  132. Mujais SK, Katz AI. Potassium deficiency. In: Seldin DW, Giebisch G, editors. The kidney: physiology and pathophysiology. Raven Press, New York 1992; p. 2249–2278.

    Google Scholar 

  133. Kirk KL, Schaefer JA. Water transport and osmoregulation by antidiuretic hormone in terminal nephron segments. In: The kidney: physiology and pathophysiology. Seldin DW, Giebisch G (editors). Raven Press, New York 1992; p. 1693–1725.

    Google Scholar 

  134. Orloff J. Handler JS. The similarity of effects of vasopressin adenosine-3′, 5′-monophosphate (cyclic AMP) and theophylline on the toad bladder. J Clin Invest 1962; 41: 702–709.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tulane University Medical Center, New Orleans, Louisiana, USA

    Jules B. Puschett, Albert W. Dreisbach & Shannan K. Eades

Authors
  1. Jules B. Puschett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert W. Dreisbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shannan K. Eades
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nephrology and Hypertension, University of Antwerp, Belgium

    Marc E. de Broe

  2. Department of Medicine, The Oregon Health Sciences University, Portland, Oregon, USA

    George A. Porter

  3. Northwest Renal Clinic, Legacy Good Samaritan Hospital, Portland, Oregon, USA

    William M. Bennett

  4. Department of Nephrology and Hypertension, University of Antwerp, Belgium

    Gert A. Verpooten

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Puschett, J.B., Dreisbach, A.W., Eades, S.K. (2003). Diuretics. In: de Broe, M.E., Porter, G.A., Bennett, W.M., Verpooten, G.A. (eds) Clinical Nephrotoxins. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2586-6_17

Download citation

  • DOI: https://doi.org/10.1007/1-4020-2586-6_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-1277-8

  • Online ISBN: 978-1-4020-2586-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation